期刊文献+

神经类固醇激素与焦虑症及抑郁症等精神疾病关系的研究进展 被引量:16

Relationship between neurosteroids and neuropsychiatric disorders such as anxiety and depression:research advances
下载PDF
导出
摘要 在中枢神经系统中,神经类固醇激素在胶质细胞内由胆固醇经过一系列酶促反应合成,主要包括脱氢表雄酮、孕烯醇酮、孕酮和四氢孕酮等,通过与γ-氨基丁酸(GABA)受体结合而发挥抗焦虑和抗抑郁样行为学效应,其中神经类固醇激素对机体内环境的稳态具有重要作用。本文就神经类固醇激素的合成、代谢,以及神经类固醇对焦虑症和抑郁症等应激反应的调控作用做一综述,并对相关机制进行探讨。 Neurosteroids are synthesized from cholesterol within the microglia of the central nervous system. They are classi?fied as dehydroepiandrosterone,progesterone,pregnenolone,allopregnanolone and other peripheral steroids. Neurosteroids such as al?lopregnanolone are positive allosteric modulators of GABAA receptors and exert anxiolytic and antidepressant-like behavior. Neuroac?tive steroids play a significant role in neurodevelopment in terms of internal environment homeostasis. This paper reviews the biosynthe?sis,metabolism regulatory effect on the response to stress and therapeutic potentials of neurosteroids.
出处 《国际药学研究杂志》 CAS CSCD 北大核心 2017年第3期236-239,共4页 Journal of International Pharmaceutical Research
基金 全军医学科技十二五面上项目(CWS12J084)
关键词 神经类固醇 精神障碍 应激 焦虑 抑郁 neurosteroids neuropsychiatric disorders stress anxiety depression
  • 相关文献

参考文献3

二级参考文献60

  • 1李云峰,罗质璞.抑郁症:神经元损伤与神经元再生障碍[J].药学学报,2004,39(11):949-953. 被引量:40
  • 2Francis SH, Turko IV, Corbin JD. Cyclic nucleotide phosphodiesterases: relating structure and function[J].Prog Nucleic Acid Res Mol Biol,2000,65:1-52.
  • 3O′Donnell JM, Frith S. Behavioral effects of family-selective inhibitors of cyclic nucleotide phosphodiesterases[J].Pharmacol Biochem Behav,1999,63(1):185-192.
  • 4Bollen E, Prickaerts J. Phosphodiesterases in neurodegenerative disorders[J].IUBMB life,2012,64(12):965-970.
  • 5O′Donnell JM. William Harvey Research Conference on PDE Inhibitors: drugs with an expanding range of therapeutic uses[J].Exp Opin Invest Drug,2000,9(3):621-625.
  • 6Zhang HT, O′Donnell JM. Effects of rolipram on scopolamine-induced impairment of working and reference memory in the radial-arm maze tests in rats[J].Psychopharmacology,2000,150(3):311-316.
  • 7Zhang HT. Phosphodiesterase targets for cognitive dysfunction and schizophrenia-a New York Academy of Sciences Meeting[J].IDrugs: Invest Drug J,2010,13(3):166-168.
  • 8Cheung YF, Kan Z, Garrett-Engele P,et al. PDE4B5, a novel, super-short, brain-specific cAMP phosphodiesterase-4 variant whose isoform-specifying N-terminal region is identical to that of cAMP phosphodiesterase-4D6(PDE4D6)[J].J Pharmacol Exp Ther,2007,322(2):600-609.
  • 9O′Donnell JM, Zhang HT. Antidepressant effects of inhibitors of cAMP phosphodiesterase (PDE4)[J].Trends Pharmacol Sci,2004,25(3):158-163.
  • 10Perez-Torres S, Miro X, Palacios JM,et al. Phosphodiesterase type 4 isozymes expression in human brain examined by in situ hybridization histochemistry and [H]3 rolipram binding autoradiography: comparison with monkey and rat brain[J].J Chem Neuroanat,2000,20(3):349-374.

共引文献63

同被引文献187

引证文献16

二级引证文献115

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部